← Eichor
Condition: Ivonescimab Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Ivonescimab

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Ivonescimab Plus Short-Course Hypofractionated Radiotherapy as Second-Line Therapy for Esophageal Squamous Cell Carcinom
Phase 2 · 1 location(s) · Anhui Provincial Hospital · NCT07188103A Study of Ivonescimab in Combination With Dato-DXd or Osimertinib in People With Non-Small Cell Lung Cancer
Phase 1/Phase 2 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT07535437Phase II Trial of Ivonescimab in Previously Treated Patients With Advanced Clear Cell Renal Cell Carcinoma
Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT06940518Ivonescimab Plus Chemotherapy in Patients With Initially Unresectable Colorectal Cancer Liver Metastases
Phase 2 · 1 location(s) · Cancer Institute and Hospital, Chinese Academy of Medical Sc · NCT06848842A Phase 2 Trial of Ivonescimab for Patients With Advanced, Metastatic Salivary Gland Cancers
Phase 2 · 2 location(s) · Glenn J. Hanna · NCT06805617Ivonescimab in Comb. With FOLFOX in Advanced HER2 Neg. GEA
Phase 2 · 2 location(s) · Massachusetts General Hospital · NCT07070466Combination Therapy for PD-1 Resistant Recurrent or Metastatic Nasopharyngeal Carcinoma: A Bayesian Adaptive Phase II Tr
Phase 2 · 6 location(s) · Ming-Yuan Chen · NCT07070479Neoadjuvant Short-Course Radiotherapy With or Without Chemotherapy and AK112 in Locally Advanced Rectal Cancer
Phase 2 · 1 location(s) · fan li · NCT06718543Ivonescimab Combined With Paclitaxel and Cisplatin as Neoadjuvant Therapy Followed by Type A Hysterectomy in Stage IB2 a
Phase 2 · 1 location(s) · Obstetrics & Gynecology Hospital of Fudan University · NCT07130240Testing Ivonescimab in Combination With Chemotherapy in Advanced or Metastatic Gastric/Gastroesophageal Adenocarcinoma
Phase 2 · 4 location(s) · UNICANCER · NCT06846346Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors
Phase 1/Phase 2 · 6 location(s) · Revolution Medicines, Inc. · NCT07397338A Study of Ivonescimab, Chemotherapy, and Stereotactic Radiosurgery for People With Non-Small Cell Lung Cancer
Phase 1/Phase 2 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT07535463Adapted Guided Stereotactic Body Radiotherapy Combined With Chemotherapy and Enhancement of Novel Drug Ivonescimab for P
Phase 1/Phase 2 · 1 location(s) · Shandong Cancer Hospital and Institute · NCT06844422A Study on Ivonescimab Plus Chemotherapy as Neoadjuvant Therapy for Borderline Resectable Pancreatic Cancer
Phase 2 · 1 location(s) · Tianjin Medical University Cancer Institute and Hospital · NCT06944106A Phase III Study of Ivonescimab + Chemo With/Without AK117 in Metastatic Pancreatic Cancer
Phase 3 · 3 location(s) · Akeso · NCT06953999Testing Ivonescimab Versus FOLFOX in Advanced Biliary Tract Cancer Patients
Phase 2 · 41 location(s) · UNICANCER · NCT06529718Study Comparing Ivonescimab Alone or Ivonescimab in Combination With Ligufalimab Versus Pembrolizumab for the Treatment
Phase 3 · 1 location(s) · Groupe Oncologie Radiotherapie Tete et Cou · NCT07264075Short-course Radiotherapy Followed by AK112 and CAPOX as Neoadjuvant Therapy for Locally Advanced Rectal Cancer
Phase 2 · 1 location(s) · Union Hospital, Tongji Medical College, Huazhong University · NCT06802666Multicenter Single-Arm Study of Ivonescimab (AK112) Combined with Chemotherapy in Pretreated Pleural Mesothelioma
Phase 2 · 1 location(s) · The First Hospital of Jilin University · NCT06875076Ivonescimab in the Treatment of Multiple Advanced Tumors
Phase 2 · 1 location(s) · Fudan University · NCT06683846A Study of Ivonescimab in People With Non-Small Cell Lung Cancer
Phase 1/Phase 2 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT07594522A Study of Ivonescimab in People With Endometrial and Cervical Cancers
Phase 2 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT06925724A Study of Ivonescimab in People With Leiomyosarcoma
Phase 2 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT07516925AK104 in Combination With AK112 Plus Chemotherapy(SOX/XELOX) as First-line Treatment for Advanced G/GEJ Cancer
Phase 2 · 1 location(s) · Harbin Medical University · NCT06196697AK112 Combined With Chemotherapy as the First-line Treatment in Advanced Esophageal Squamous Cell Carcinoma Patients
Phase 2 · 1 location(s) · Tianjin Medical University Cancer Institute and Hospital · NCT06489197Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients
Phase 3 · 253 location(s) · Summit Therapeutics · NCT05899608Mechanism of Enhanced Efficacy of Ivonescimab in Neoadjuvant Therapy for Non-Small Cell Lung Cancer
Phase N/A · 1 location(s) · Peking University People's Hospital · NCT07359040Ivonescimab(AK112/SMT112) in Combination With Stereotactic Body Radiation Therapy and Chemotherapy in Patients With Panc
Phase 2 · 1 location(s) · Union Hospital, Tongji Medical College, Huazhong University · NCT06491472A Study of AK112 as Consolidation Treatment for Patients With Limited Stage Small-cell Lung Cancer Who Have Not Progress
Phase 3 · 53 location(s) · Akeso · NCT07010263Evaluating Ivonescimab as a Potential Treatment for Pleural Mesothelioma Patients Whose Cancer Has Returned After Previo
Phase 2 · 20 location(s) · Intergroupe Francophone de Cancerologie Thoracique · NCT06840834
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.